TG Therapeutics (TGTX) Misses Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
H.C. Wainwright Resumes TG Therapeutics (TGTX) at Buy
August 12, 2015 7:24 AM EDTH.C. Wainwright resumed coverage on TG Therapeutics (NASDAQ: TGTX) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on TG Therapeutics click here. For more ratings news on TG Therapeutics click here.
Shares of TG Therapeutics closed at $16.11 yesterday.
... MoreTG Therapeutics (TGTX) Continuing to Drive on All Cylinders; Roth Affirms 'Focus Pick' Rating
August 10, 2015 11:27 AM EDTRoth Capital reaffirms TG Therapeutics, Inc. (Nasdaq: TGTX) with a Focus Pick rating and $33 price target following... More
